Genetic susceptibility, risk prediction, and druggable targets for oropharyngeal cancer: a UK Biobank study
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Purpose This study aimed to systematically identify and annotate oropharyngeal cancer (OPC) genetic risk, construct OPC risk prediction models, and identify candidate drug targets for OPC treatment. Methods The OPC genome-wide association study was conducted in the UK Biobank involving 208 OPC patients and 328,248 healthy individuals. Functional annotations were performed using the FUMA website and the Sclinker statistical framework. OPC risk prediction models were constructed using logistic regression. Mendelian randomization (MR) was employed to identify potential OPC-related drug target genes. Results We identified 43 OPC risk genetic variants with p < 1E-06, which mapped to 7 independent loci. We also revealed significant tissue-level OPC single nucleotide polymorphism heritability enrichments in heart, kidney, and muscle, and cell-type specific enrichments in B cells, T cells, endothelial cells, epithelial cells, and fibroblasts. We further constructed four OPC risk prediction models, and the fully-adjusted model demonstrated moderate discriminative ability in internal validation. Additionally, MR analysis identified 160 nominate OPC-associated candidate druggable genes using expression/protein quantitative trait loci as instrumental variables. Drugs targeting these genes, such as Daunorubicin, Gefitinib, and Ibrutinib had been approved as anti-cancer agents. Conclusion These results advanced our understanding of the genetic architecture of OPC and provided insights into its risk prediction and potential drug targets, contributing to future development of improved OPC prevention and treatment strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Yazar, S., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00913-z · Cited by 2,607
Plasma proteomic associations with genetics and health in the UK Biobank
Sun, B. B., Chiou, J., Traylor, M., Benner, C., Hsu, Y.-H., Richardson, T. G., Surendran, P., Mahajan, A., Robins, C., Vasquez-Grinnell, S. G., et al. (2023) · Nature · doi:10.1038/s41586-023-06592-6 · Cited by 1,880
Large-scale integration of the plasma proteome with genetics and disease
Ferkingstad, E., Sulem, P., Atlason, B. A., Sveinbjornsson, G., Magnusson, M. I., Styrmisdottir, E. L., Gunnarsdottir, K., Helgason, A., Oddsson, A., Halldorsson, B. V., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00978-w · Cited by 1,697
Kelley, R. K., Ueno, M., Yoo, C., Finn, R. S., Furuse, J., Ren, Z., Yau, T., Klümpen, H.-J., Chan, S. L., Ozaka, M., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00727-4 · Cited by 1,169
Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands
Goldgar, D. E., Easton, D. F., Cannon-Albright, L. A., & Skolnick, M. H. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.21.1600 · Cited by 1,031
The druggable genome and support for target identification and validation in drug development
Finan, C., Gaulton, A., Kruger, F. A., Lumbers, R. T., Shah, T., Engmann, J., Galver, L., Kelley, R., Karlsson, A., Santos, R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1166 · Cited by 1,026
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management
Lechner, M., Liu, J., Masterson, L., & Fenton, T. R. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00603-7 · Cited by 979
Junctional adhesion molecules (JAMs): more molecules with dual functions?
Ebnet, K., Suzuki, A., Ohno, S., & Vestweber, D. (2004) · Journal of Cell Science · doi:10.1242/jcs.00930 · Cited by 501
Massarelli, E., William, W., Johnson, F., Kies, M., Ferrarotto, R., Guo, M., Feng, L., Lee, J. J., Tran, H., Kim, Y. U., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4051 · Cited by 490
Kürten, C. H. L., Kulkarni, A., Cillo, A. R., Santos, P. M., Roble, A. K., Onkar, S., Reeder, C., Lang, S., Chen, X., Duvvuri, U., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27619-4 · Cited by 293
Jagadeesh, K. A., Dey, K. K., Montoro, D. T., Mohan, R., Gazal, S., Engreitz, J. M., Xavier, R. J., Price, A. L., & Regev, A. (2022) · Nature Genetics · doi:10.1038/s41588-022-01187-9 · Cited by 239
Lesseur, C., Diergaarde, B., Olshan, A. F., Wünsch-Filho, V., Ness, A. R., Liu, G., Lacko, M., Eluf-Neto, J., Franceschi, S., Lagiou, P., et al. (2016) · Nature Genetics · doi:10.1038/ng.3685 · Cited by 238
Bachy, E., Camus, V., Thieblemont, C., Sibon, D., Casasnovas, R.-O., Ysebaert, L., Damaj, G., Guidez, S., Pica, G. M., Kim, W. S., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01815 · Cited by 197
Self-citationJAM4, a Junctional Cell Adhesion Molecule Interacting with a Tight Junction Protein, MAGI-1
Hirabayashi, S., Tajima, M., Yao, I., Nishimura, W., Mori, H., & Hata, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4267-4282.2003 · Cited by 183
Su, W.-M., Gu, X.-J., Dou, M., Duan, Q.-Q., Jiang, Z., Yin, K.-F., Cai, W.-C., Cao, B., Wang, Y., & Chen, Y.-P. (2023) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-331142 · Cited by 161
Negri, E., Boffetta, P., Berthiller, J., Castellsague, X., Curado, M. P., Maso, L. D., Daudt, A. W., Fabianova, E., Fernandez, L., Wünsch‐Filho, V., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.23848 · Cited by 159
Global epidemiologic patterns of oropharyngeal cancer incidence trends
Zumsteg, Z. S., Luu, M., Rosenberg, P. S., Elrod, J. K., Bray, F., Vaccarella, S., Gay, C., Lu, D. J., Chen, M., Chaturvedi, A. K., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad169 · Cited by 146
Ferrarotto, R., Bell, D., Rubin, M. L., Hutcheson, K. A., Johnson, J. M., Goepfert, R. P., Phan, J., Elamin, Y. Y., Torman, D., Warneke, C. L., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3977 · Cited by 134
JAM-related proteins in mucosal homeostasis and inflammation
Luissint, A.-C., Nusrat, A., & Parkos, C. A. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0421-0 · Cited by 118
Welsh, S., Peakman, T., Sheard, S., & Almond, R. (2017) · BMC Genomics · doi:10.1186/s12864-016-3391-x · Cited by 108
Puram, S. V., Mints, M., Pal, A., Qi, Z., Reeb, A., Gelev, K., Barrett, T. F., Gerndt, S., Liu, P., Parikh, A. S., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01357-3 · Cited by 106
Correale, P., Tagliaferri, P., Fioravanti, A., Del Vecchio, M. T., Remondo, C., Montagnani, F., Rotundo, M. S., Ginanneschi, C., Martellucci, I., Francini, E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5278 · Cited by 78
Shete, S. S., Liu, H., Wang, J., Yu, R. K., Sturgis, E. M., Li, G., Dahlstrom, K. R., Liu, Z., Amos, C. I., & Wei, Q. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2360 · Cited by 58
Zhong, Z., Liu, C., Xu, Y., Si, W., Wang, W., Zhong, L., Zhao, Y., & Dong, X. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102632 · Cited by 52
Self-citationCitro, S., Bellini, A., Miccolo, C., Ghiani, L., Carey, T. E., & Chiocca, S. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0394-9 · Cited by 49
Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer
Ferreiro-Iglesias, A., McKay, J., Brenner, N., Virani, S., Lesseur, C., Gaborieau, V., Ness, A., Hung, R. J., Liu, G., Diergaarde, B. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26151-9 · Cited by 46
Cheng, D., Qiu, K., Rao, Y., Mao, M., Li, L., Wang, Y., Song, Y., Chen, J., Yi, X., Shao, X., et al. (2023) · eLife · doi:10.7554/elife.82705 · Cited by 41
Self-citationKoyanagi, Y. N., Ito, H. M., Oze, I., Hosono, S., Tanaka, H., Abe, T., Shimizu, Y., Hasegawa, Y., & Matsuo, K. (2016) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000222 · Cited by 32
Risk prediction models for head and neck cancer in the US population from the INHANCE consortium
Lee, Y.-C. A., Al-Temimi, M., Ying, J., Muscat, J., Olshan, A. F., Zevallos, J. P., Winn, D. M., Li, G., Sturgis, E. M., Morgenstern, H., et al. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwz259 · Cited by 32
Vorinostat as potential antiparasitic drug.
Herrera-Martínez, M., Orozco-Samperio, E., Montaño, S., Ariza‐Ortega, J. A., Flores-García, Y., & López-Contreras, L. (2020) · PubMed · doi:10.26355/eurrev_202007_21909 · Cited by 27
Tajima, M., Hirabayashi, S., Yao, I., Shirasawa, M., Osuga, J.-I., Ishibashi, S., Fujita, T., & Hata, Y. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00673.x · Cited by 25
Chien, H., Young, C., Chen, T.-P., Liao, C., Wang, H., Cheng, S., & Huang, S. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0449 · Cited by 24
Cross-ancestral GWAS identifies 29 variants across head and neck cancer subsites
Ebrahimi, E., Sangphukieo, A., Park, H. A., Gaborieau, V., Ferreiro-Iglesias, A., Diergaarde, B. B., Ahrens, W., Alemany, L., Arantes, L. M., Betka, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63842-z · Cited by 24
Thibodeaux, S. R., Barnett, B. B., Pandeswara, S., Wall, S. R., Hurez, V. J., Dao, V. A., Sun, L., Daniel, B. J., Brumlik, M. J., Drerup, J. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4594 · Cited by 21
Budhathoki, S., Diergaarde, B. B., Liu, G., Olshan, A. F., Ness, A., Waterboer, T., Virani, S., Basta, P. V., Bender, N., Brenner, N., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34444 · Cited by 20
Tao, Y., Sturgis, E. M., Huang, Z., Sun, Y., Dahlstrom, K. R., Wei, Q., & Li, G. (2018) · International Journal of Cancer · doi:10.1002/ijc.31530 · Cited by 13
Tao, Y., Gross, N. D., Liu, Y., Zhang, L., Li, G., Huang, Z., & Yang, J. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.10.006 · Cited by 11
Chen, Y., Jin, N., Li, X., Fan, T., Deng, X., Liang, D., & Song, G. (2021) · Journal of Immunology Research · doi:10.1155/2021/6661625 · Cited by 11
Risk prediction models for head and neck cancer: A rapid review
Smith, C. D. L., McMahon, A. D., Ross, A. J., Inman, G. J., & Conway, D. I. (2022) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.982 · Cited by 11
Lu, Z., Zhou, X., Fu, L., Li, Y., Tian, T., Liu, Q., & Zou, H. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073375 · Cited by 6
Ali, M. K. M., Abounader, D., Rybicki, L. A., Yurch, M. A., Starn, J., Ferraro, C. S., Winslow, V. A., Hamilton, B. K., Gerds, A. T., Liu, H. D., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.01.077 · Cited by 4
León, X., García, J., Pujol, A., Beltrán, J. D. J., Vásquez, R., Quer, M., & Camacho, M. (2022) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-021-07223-4 · Cited by 4
Research works printed but not linked: 2
- Garst J (2007) Topotecan: an evolving option in the treatment of relapsed small cell lung cancer. Ther Clin Risk Manag 3(6):1087–1095
- (2012) Aldesleukin. In: LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. https://www.ncbi.nlm.nih.gov/books/NBK547852/
Cited by
Translational head and neck oncology
Avilés‐Jurado, F. X. (2026) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-026-10788-7
Metadata
- Authors
- Li, J., Qiu, K., Rao, Y., Cheng, D., Song, Y., Shao, X., Jiang, C., Shu, T., Xu, W., Zhao, Y., & Ren, J.
- Affiliations
- Sichuan University (CN)
- Princess Margaret Cancer Centre (CA)
- Corresponding author
- Xu, Wei
- Zhao, Yu
- Ren, Jianjun
- Venue
- European Archives of Oto-Rhino-Laryngology
- Published
- 2026-10-04
- ISSN
- 0937-4477 (ISSN-L)
- 1434-4726
- OpenAlex
- W7219746469
- Cited by
- 0
- References
- 44
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- European Archives of Oto-Rhino-Laryngology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82272777, 82471153, 82403589)
- Science and Technology Department of Sichuan Province (2025ZNSFSC1528, 2025ZNSFSC1530)
- Chengdu Science and Technology Bureau (2024-YF05-00908-SN)
- 1·3·5 project for disciplines of excellence-Clinical Research Fund, West China Hospital, Sichuan University (2025HXFH010)
- 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (2025-522)
- Sichuan University Interdisciplinary Innovation Fund
- Topics
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- oropharyngeal cancer, genetic susceptibility, risk prediction, druggable targets, UK Biobank, cancer genetics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.